Akari Therapeutics Income Statement (2011-2026) | AKTX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2011 Dec2012 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Dec2016 Dec2017 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Dec2021 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Shares Outstanding (Entity) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.01B0.01B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)
0.01B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.10B0.00B0.00B0.00B0.00B0.00B
Restructuring Costs (Quarter)
0.00B0.00B0.00B
Other Operating Expenses (Quarter)
-0.00B0.01B
Operating Expenses (Quarter)
0.01B0.00B0.01B0.00B0.01B0.00B0.00B0.00B0.01B0.01B0.01B0.00B0.11B0.00B0.00B0.00B0.00B0.02B
Operating Income (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.11B-0.00B-0.00B-0.01B-0.00B-0.02B
EBIT (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.11B-0.00B-0.00B-0.01B-0.00B-0.02B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.01B-0.00B0.00B0.00B-0.03B-0.00B-0.00B0.00B0.00B0.00B
Non Operating Income (Quarter)
-0.00B0.00B-0.00B0.00B0.00B0.01B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B
Net income details
EBT (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.02B
Tax Provisions (Quarter)
-0.00B0.00B-0.00B
Profit After Tax (Quarter)
0.00B-0.00B-0.01B0.00B-0.01B0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.00B-0.14B-0.00B-0.00B-0.00B-0.00B-0.01B
Income from Continuing Operations (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
Consolidated Net Income (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
Income towards Parent Company (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
Net Income towards Common Stockholders (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
Additional items
EPS (Basic) (Quarter)
-3.42-1.57-1.71-0.06-1.74-0.02-0.02-0.01-0.02-0.02-0.020.00-0.010.000.000.000.000.00
EPS (Diluted) (Quarter)
-3.42-2.15-2.58-0.11-1.74-0.02-0.02-0.01-0.02-0.02-0.020.00-0.010.000.000.000.000.00
Shares Outstanding (Quarter)
0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.19B0.25B0.25B0.24B0.34B0.47B0.61B0.60B1.36B1.57B1.63B1.68B118.76B
Shares Outstanding (Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.19B0.25B0.25B0.24B0.34B0.47B0.61B0.60B1.36B1.57B1.63B1.68B118.76B
EBITDA (Quarter)
-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.00B-0.11B-0.00B-0.00B-0.01B-0.00B-0.02B
Interest Expenses (Quarter)
0.03B0.03B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B
Tax Rate (Quarter)
14.53-1.635.61